International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | £239,549 | £259,651 | £261,357 | £267,585 |
| - Cash | £14,980 | £10,433 | £0 | £0 |
| + Debt | £29,607 | £22,827 | £32,474 | £39,976 |
| Enterprise Value | £254,176 | £272,045 | £293,831 | £307,561 |
| Revenue | £18,686 | £42,338 | £8,494 | £22,143 |
| % Growth | -55.9% | 398.4% | -61.6% | – |
| Gross Profit | £14,383 | £40,140 | £6,170 | -£13,583 |
| % Margin | 77% | 94.8% | 72.6% | -61.3% |
| EBITDA | -£21 | £39,553 | £0 | £0 |
| % Margin | -0.1% | 93.4% | 0% | 0% |
| Net Income | -£1,170 | £38,876 | £6,813 | -£22,473 |
| % Margin | -6.3% | 91.8% | 80.2% | -101.5% |
| EPS Diluted | -0.033 | 1.02 | 0.17 | -0.55 |
| % Growth | -103.2% | 500% | 130.9% | – |
| Operating Cash Flow | £28,633 | £45,352 | £27,299 | £1,124 |
| Capital Expenditures | -£28,633 | £0 | £0 | £0 |
| Free Cash Flow | £0 | £45,352 | £27,299 | £1,124 |